Scott Barton, MD

Scott Barton, MD, is a radiation oncologist at Kelsey-Seybold. He earned his Bachelor of Science in biochemistry from the University of Notre Dame in 2011, graduating cum laude, and his medical degree from Indiana University School of Medicine in 2015, graduating with early Alpha Omega Alpha Honor Society distinction. In 2020, he completed his Radiation Oncology residency at Baylor College of Medicine in Houston. After completing his radiation oncology training, Dr. Barton continued on as assistant professor of radiation oncology at Baylor College of Medicine, where his focus was on gastrointestinal and thoracic malignancies as well as the treatment of oligometastatic disease. He became board-certified at the earliest opportunity in September 2021 and joined Kelsey-Seybold in January 2022.

Dr. Barton is a member of the American Society for Radiation Oncology, the American College of Radiology, the American Society of Clinical Oncology, the American Brachytherapy Society, the Texas Radiological Society, the Texas Medical Association, and the Harris County Medical Society.

Dr. Barton is a fan of college football and roots for his alma mater. He enjoys the holidays and traveling.

Fun Facts

Dr. Barton’s guilty pleasures are playing board games that are way too complicated and putting together thousand-piece puzzles.

Even as a child, Dr. Barton wanted to become a scientist and do cancer research. However, as he made his way through school and research internships, he quickly realized he much preferred the clinic and treating patients directly.

• In 2019, Dr. Barton was a finalist for the Texas Radiological Society (TRS) Brown Family Award for Resident Excellence in Radiation Oncology.
• Alpha Omega Alpha early election as a junior medical student in 2013.

Oral Presentations

• Thoracic Working Group: LU-006 Trial Implementation at Baylor College of Medicine; August 3, 2020; Houston, TX
• Grand Rounds: Hodgkin’s Lymphoma: Evolving Treatment Paradigms at Baylor College of Medicine; March 20, 2020; Houston, TX
• Journal Club: Advanced Stage Endometrial Cancer, GOG 258 and PORTEC-3 at Baylor College of Medicine; September 13, 2019; Houston, TX
• Total Neoadjuvant Therapy for Rectal Cancer at Annual Texas Radiological Society Conference; March 30, 2019; Austin, TX
• Morbidity and Mortality: Breast Fibrosis as a Late Toxicity of Radiation Therapy at DeBakey VA Medical Center; March 2019; Houston, TX
• Non-Hodgkin’s Lymphoma Didactic Education at Baylor College of Medicine; February 2019; Houston, TX
• Introduction to Baylor Radiation Oncology and the City of Houston at the Baylor College of Medicine Radiation Oncology Resident Interview Day; Annually 2017 – 2019; Houston, Texas
• Grand Rounds: Pediatric Rhabdomyosarcoma at Baylor College of Medicine; November 2018; Houston, TX
• Grand Rounds: Efficacy of ADT in Salvage Prostate Cancer at Baylor College of Medicine; November 2017; Houston, TX
• Morbidity and Mortality: Fistula Formation as a Late Toxicity of Radiation Therapy at DeBakey VA Medical Center; September 2017; Houston, TX
• Grand Rounds: Bladder Preservation Therapy at Baylor College of Medicine; January 2017; Houston, TX
• Journal Club: Regional Nodal Irradiation in Breast Cancer at Baylor College of Medicine; October 2016; Houston, TX
• Morbidity and Mortality: Management of ACEi-Induced Angioedema at Aurora Health; March 2016; Milwaukee, WI
• Diagnosis and Management of Pulmonary Embolism at Aurora Health; November 2015; Milwaukee, WI
• Radiographic Diagnosis of Hepatocellular Carcinoma at Aurora Health; August 2015; Milwaukee, WI
• Grand Rounds: Soft Tissue Sarcoma of the Extremity; Indiana School of Medicine, June 2010; Indianapolis, IN. Rush University Medical Center, July 2010; Chicago, IL. UT Southwestern Medical Center, August 2010; Dallas, TX.

Publications and Poster Presentations

• Xie J, Bartels CM, Barton SW, Gu D. Targeting hedgehog signaling in cancer: research and clinical developments. OncoTargets and Therapy 2013; 6:1425 –1435.
• Barton SW, Gu D, Xie J. Reduction of Pancreatic Tumor Metastasis using Hedgehog and MAP Kinase Inhibitors, IUSM Student Research Program in Academic Medicine, Indianapolis, IN; August 2012.

Research

• ECOG-ACRIN 2183; NCT04248452, 05/2021 – 09/2021
• Institutional Secondary Investigator, Clinical Trial – Houston, TX
• SWOG S1827 (MAVERICK); NCT04155034, 10/2020 – 09/2021
• Medical Student Research Assistant – Indianapolis, IN
• Student Research Program in Academic Medicine
• Principal Investigator – Dr. Jingwu Xie, Department of Pediatrics, 05/2012 – 08/2012
• Undergraduate Research Assistant – Notre Dame, IN
• Primary Investigator – Dr. Brian Baker, 08/2009 – 09/2010
• Undergraduate Research Assistant – Indianapolis, IN
• Clinical and Translational Sciences Institute Internship
• Principal Investigator – Dr. Philip Johnson, Institute of Psychiatric Research at IUPUI, Summer 2009